)
)
)
Transneural Therapeutics
Transneural is a preclinical-stage biotechnology company transforming the treatment of neuropsychiatric and neurodegenerative diseases with novel rapid-acting therapies. Transneural is led by globally recognized clinical development and commercialization leaders in neuropsychiatry and neurodegeneration. Transneural’s pipeline agents target G-protein-coupled receptors known to be validated drug targets with therapeutics built on entirely novel chemical scaffolds identified by bridging AI with human intervention.
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
